Rachel Schiff

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.649Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

UNC Libraries(2020)10.17615/43yk-w772

Top 31%

0.649DataRank

Top 31%17 citations

Qing Lai, Pavel Zuloaga, Amber M. Froehlich, Edward S. Chen, Jian Huang +24 more

Papers

Driven by 25 papers — median percentile 69. Top paper: “Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer”.

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4191

N/A

4.0DataRank · unranked

96 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

Scientific Reports(2022)10.1038/s41598-022-05949-7

N/A

0.912DataRank · unranked

27 citations

Hariprasad Thangavel, Noor Mazin Abdulkareem, Suhas Vasaikar, Carmine De Angelis, Leon Bae +7 more

Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2975

N/A

0.907DataRank · unranked

35 citations

Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Héraud, Albert Grinshpun +26 more

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Proceedings of the National Academy of Sciences(2016)10.1073/pnas.1612835113

N/A

0.784DataRank · unranked

185 citations

Rinath Jeselsohn, Resel Pereira, Emporia F. Hollingsworth, Chad J. Creighton, Fugen Li +22 more

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

Nature Cell Biology(2020)10.1038/s41556-020-0514-z

N/A

0.741DataRank · unranked

139 citations

Zhao Zhang, Yi‐Zhou Jiang, Pengya Xue, Hu Wang, Zhao Lai +16 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2

N/A

0.722DataRank · unranked

122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

UNC Libraries(2020)10.17615/43yk-w772

Top 31%

0.649DataRank

Top 31%17 citations

Qing Lai, Pavel Zuloaga, Amber M. Froehlich, Edward S. Chen, Jian Huang +24 more

The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms(2020)10.1016/j.bbagrm.2020.194631

N/A

0.489DataRank · unranked

25 citations

Lavanya Choppavarapu, Kun Fang, Alireza Sahaf Naeini, Bakhtiyor Nosirov, Jingwei Li +9 more

High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer

Cell Reports(2023)10.1016/j.celrep.2023.112821

N/A

0.483DataRank · unranked

24 citations

Resel Pereira, Chia-Chia Liu, Carmine De Angelis, Martin J. Shea, Sarmistha Nanda +17 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0.470DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.29.486217

N/A

0.130DataRank · unranked

1 citations

Xintao Qiu, Ariel Feiglin, Xiaoyong Fu, Sándor Spisák, Avery Feit +20 more

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

npj Breast Cancer(2021)10.1038/s41523-021-00274-0

N/A

0DataRank · unranked

11 citations

Carolina Gutiérrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J. Shea +16 more

Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance

Breast Cancer Research(2020)10.1186/s13058-020-01325-3

N/A

0DataRank · unranked

35 citations

Ling Lin, Jamunarani Veeraraghavan, Yiheng Hu, Xian Wang, Sanghoon Lee +4 more

Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.26.149948

N/A

0DataRank · unranked

3 citations

Ling Lin, Jamunarani Veeraraghavan, Yiheng Hu, Xian Wang, Sanghoon Lee +4 more

Data from Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

(2023)10.1158/1078-0432.c.6531045

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jinah Kim +13 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603.v1

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Microscaled proteogenomic methods for precision oncology

UNC Libraries(2024)10.17615/rb11-7v56

N/A

0DataRank · unranked

0 citations

B Zhang, F. O. Ademuyiwa, Prashant R. Singh, Charles M. Perou, Alexander B. Saltzman +28 more

Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancer

British Journal of Pharmacology(2025)10.1111/bph.17463

N/A

0DataRank · unranked

6 citations

Raksha R. Bhat, Micah Castillo, Sung Yun Jung, Suhas Vasaikar, Sarmistha Nanda +12 more

Effect of mevalonate pathway inhibitors on outcomes of patients (pts) with HER2-positive early breast cancer (BC) in the ALTTO trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.522

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Lieveke Ameye, Marianne Paesmans, Sarra El-Abed +13 more

A Noncompetitive Small Molecule Inhibitor of Estrogen-regulated Gene Expression and Breast Cancer Cell Growth That Enhances Proteasome-dependent Degradation of Estrogen Receptor α

UNC Libraries(2020)10.17615/f1f8-1d34

N/A

0DataRank · unranked

0 citations

Steven K. Nordeen, Paul J. Hergenrother, Elizabeth M. Wilson, Nicole M. Kretzer, Rachel Schiff +5 more

The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells

Developmental Cell(2021)10.1016/j.devcel.2021.03.008

N/A

0DataRank · unranked

119 citations

Weijie Zhang, Jingyuan Hu, Zhan Xu, Hai Wang, Poonam Sarkar +21 more

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

The FASEB Journal(2021)10.1096/fj.202100070r

N/A

0DataRank · unranked

25 citations

Raksha R. Bhat, Lanfang Qin, Suhas Vasaikar, Ambily Gopinathan, Tamika Mitchell +8 more

Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2

Cancer Cell(2021)10.1016/j.ccell.2021.08.007

N/A

0DataRank · unranked

14 citations

Rachel Schiff, Albert Grinshpun, Rinath Jeselsohn

Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2961

N/A

0DataRank · unranked

12 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jin-Ah Kim +13 more

Rachel Schiff

Indexed papers

Top data-sharing exemplar

Papers